跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sapheron - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Sapheron
Approved
STANDARD
Sapheron
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b0923f179ac1fe23
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
b0923f179ac1fe23
Drug Approval Philippines Name
Sapheron
Product Name
Sapheron
Registration Number
DRP-12512
Brand Name
Sapheron
Generic Name
Iron
Dosage Form
Capsule
Dosage Strength
75 mg (equivalent to 250 mg Ferrous Sulfate)
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Ollen Pharma Trading Inc.
Distributor
Ollen Pharma Trading Inc.
Issuance Date
26 August 2022
Expiry Date
26 August 2027
Pharmacologic Category
Hematinic
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b0923f179ac1fe23
Type
Standard
Back to Philippines FDA Approvals